PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1235934
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1235934
Cancer Registry Software Market Forecasts to 2028 - Global Analysis By Type, Database Type, Functionality, Deployment Model, End User and Geography
According to Stratistics MRC, the Global Cancer Registry Software Market is accounted for $59.72 billion in 2022 and is expected to reach $112.32 billion by 2028 growing at a CAGR of 11.1% during the forecast period. The cancer registry software automates data collecting for national and state registries, which aids in tracking the effectiveness of various treatment regimens. Furthermore, the data collected by the state registries aid in better understanding and treatment of the condition. The information gathered is critical in identifying risk factors such as tobacco usage, sun exposure, or environmental risks such as chemical and radiation exposure. This data is also required for determining where screening and treatment options should be tracked and improved. Furthermore, registry data can help research institutes measure the effectiveness of cancer management, treatment, and preventive programmes.
According to Proteus Breach, healthcare sector saw a massive 41.4 million patient records breached in 2019.
Market Dynamics:
Driver:
Growing prevalence of cancer cases
Breast, cervical, and prostate cancers are extremely common in the populations of the United States and Europe. To track trends and examine the possible causes of cancer, medical researchers require up-to-date data on cancer, such as the population diagnosed with cancer, patients undergoing treatment, and mortality rate. Healthcare professionals require cancer incidence statistics in order to make judgements about the amount of equipment and drugs to purchase for treatment and awareness. The increased usage of cancer registry systems for data collecting, storage, and management would have a favourable impact on the market focus during the projection period.
Restraint:
Data privacy and security
Data privacy and security issues, as the system collects highly personal data, will be a major barrier for the cancer registry software market over the projection period. Cancer registries collect information such as patient demographics, tumour features, treatment, and disease outcome. Government agencies are concentrating on the implementation of new regulations and laws to ensure the safe management of information. Various federal regulations are also listed in the Health Insurance Portability and Accountability Act and the US Department of Health and Human Services (HHS) for the protection and privacy of consumer health data.
Opportunity:
Increasing clinical research for oncology
Clinical trials are being conducted by pharmaceutical companies and research organisations in order to develop novel cancer treatment techniques. Clinical trials and in-depth analyses of registry data during clinical research aid in the identification of proper monitoring of cancer causes and therapies. Cancer registries are used by research institutes and pharmaceutical corporations as a follow-up source during phase III and phase IV clinical studies. The development of sophisticated cancer registry software assists public and private cancer registry organisations in improving data quality. This will help the market's expansion in the coming years.
Threat:
Lack of interoperability and integration
The lack of connectivity between EHR systems and independent cancer patient registration software has impeded the development of novel alternatives. These types of data exchange problems are expected to continue to necessitate manual methods for importing or exporting patient records between different EHR systems until a universal health information exchange system is built throughout a country/region. As a result, broad adoption of EHRs that are not fully compatible poses a significant problem for cancer patient registry software suppliers.
COVID-19 Impact
Because of the COVID-19 pandemic, cancer diagnoses declined considerably during the pandemic, as did chemotherapy, surgery, and other supporting cancer treatments. Doctors were urged to postpone post-endoscopic resection, surgical resection of cancer, and post-polypectomy cancer. They also recommended that screening for high-risk cancer patients be postponed due to the risk of infection, which resulted in a reduction in treatment operations. A government commitment to fund future registry operations as a disease control asset, along with a shift towards electronic reporting systems, would help to secure the global sustainability of cancer surveillance.
The integrated software segment is expected to be the largest during the forecast period
The integrated software segment is estimated to have a lucrative growth, due to the increasing demand for integrating software with a regional oncology network. This will aid in tracking affected geographic locations and evaluating the treatment intervention. It will also contribute in the collection of data on illness burden and the success of treatment programmes. Furthermore, linkage with screening archives is required to identify screen-detected cancers and improve evaluation procedures. These factors are projected to drive the expansion of this segment in the next years.
The commercial database segment is expected to have the highest CAGR during the forecast period
The commercial database segment is anticipated to witness the fastest CAGR growth during the forecast period, due to its advantage of data safety as compared to the public database. The commercial database complies with most federal requirements and codes. The data is also well-structured and simple to follow. Commercial technologies enable data transmission among government research agencies such as the Centers for Disease Control and Prevention (CDC) and central cancer registries.
Region with largest share:
North America is projected to hold the largest market share during the forecast period owing to the presence of developed infrastructure. The region's advanced infrastructure and increased investment in research & development for innovation are important factors driving the growth of the cancer registry software market. Cancer is the second highest cause of mortality in the United States, according to the National Institutes of Health (NIH). The rising incidence of cancer in this region, owing to cigarette use and a lack of physical exercise, among other factors, is fuelling market expansion.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to increasing government initiatives being undertaken in this region. In Japan, the Ministry of Health, Labour, and Welfare has launched projects to strengthen the country's healthcare infrastructure. China has also unveiled its 12th Five-Year Plan to improve the country's Regional Healthcare Information Networks (RHINs). Furthermore, the movement of pharmaceutical businesses to low-cost manufacturing countries such as China and India is moving the Asia Pacific industry forward.
Key players in the market
Some of the key players profiled in the Cancer Registry Software Market include: IBM Corporation, McKesson Corporation, Himagine Solutions Inc., CONDUENT Inc., C/Net Solutions, Elekta AB, Rocky Mountain Cancer Data Systems, Ordinal Data Inc., Electronic Registry Systems Inc., Onco Inc., F. Hoffmann-La Roche Ltd, Netdox Health Pvt. Ltd. and Centers for Disease Control and Prevention
Key Developments:
In March 2022, Elekta stated that National Health Service Supply Chain (NHSSC) had ordered multiple licenses for Elekta's ProKnow software solution, which centralizes and analyzes radiotherapy data in a secure, scalable platform, accessible to the NHS England's (NHSE's) radiation oncology facilities throughout the country.
In November 2018, Onco upgraded the OncoLog Version 4.4.0 to include the newest requirements mandated by NAACCR, AJCC, CoC and SEER.
Types Covered:
- Standalone Software
- Integrated Software
Database Types Covered:
- Public Database
- Commercial Database
Functionalities Covered:
- Product Outcome Evaluation
- Cancer Reporting to Meet State and Federal Regulations
- Medical Research & Clinical Studies
- Patient Care Management
Deployment Models Covered:
- Cloud-based
- On-premise
End Users Covered:
- Research Centre
- Hospitals & Medical Practices
- Private Payers
- Pharmaceutical, Biotechnology, and Medical Device Companies
- Government Organizations & Third-Party Administrators
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 End User Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Cancer Registry Software Market, By Type
- 5.1 Introduction
- 5.2 Standalone Software
- 5.3 Integrated Software
6 Global Cancer Registry Software Market, By Database Type
- 6.1 Introduction
- 6.2 Public Database
- 6.3 Commercial Database
7 Global Cancer Registry Software Market, By Functionality
- 7.1 Introduction
- 7.2 Product Outcome Evaluation
- 7.3 Cancer Reporting to Meet State and Federal Regulations
- 7.4 Medical Research & Clinical Studies
- 7.5 Patient Care Management
8 Global Cancer Registry Software Market, By Deployment Model
- 8.1 Introduction
- 8.2 Cloud-based
- 8.3 On-premise
9 Global Cancer Registry Software Market, By End User
- 9.1 Introduction
- 9.2 Research Centre
- 9.3 Hospitals & Medical Practices
- 9.4 Private Payers
- 9.5 Pharmaceutical, Biotechnology, and Medical Device Companies
- 9.6 Government Organizations & Third-Party Administrators
10 Global Cancer Registry Software Market, By Geography
- 10.1 Introduction
- 10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
- 10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
- 10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
- 10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa
11 Key Developments
- 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 11.2 Acquisitions & Mergers
- 11.3 New Product Launch
- 11.4 Expansions
- 11.5 Other Key Strategies
12 Company Profiling
- 12.1 IBM Corporation
- 12.2 McKesson Corporation
- 12.3 Himagine Solutions Inc.
- 12.4 CONDUENT Inc.
- 12.5 C/Net Solutions
- 12.6 Elekta AB
- 12.7 Rocky Mountain Cancer Data Systems
- 12.8 Ordinal Data Inc.
- 12.9 Electronic Registry Systems Inc.
- 12.10 Onco Inc.
- 12.11 F. Hoffmann-La Roche Ltd
- 12.12 Netdox Health Pvt. Ltd.
- 12.13 Centers for Disease Control and Prevention
List of Tables
- Table 1 Global Cancer Registry Software Market Outlook, By Region (2020-2028) ($MN)
- Table 2 Global Cancer Registry Software Market Outlook, By Type (2020-2028) ($MN)
- Table 3 Global Cancer Registry Software Market Outlook, By Standalone Software (2020-2028) ($MN)
- Table 4 Global Cancer Registry Software Market Outlook, By Integrated Software (2020-2028) ($MN)
- Table 5 Global Cancer Registry Software Market Outlook, By Database Type (2020-2028) ($MN)
- Table 6 Global Cancer Registry Software Market Outlook, By Public Database (2020-2028) ($MN)
- Table 7 Global Cancer Registry Software Market Outlook, By Commercial Database (2020-2028) ($MN)
- Table 8 Global Cancer Registry Software Market Outlook, By Functionality (2020-2028) ($MN)
- Table 9 Global Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2020-2028) ($MN)
- Table 10 Global Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2020-2028) ($MN)
- Table 11 Global Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2020-2028) ($MN)
- Table 12 Global Cancer Registry Software Market Outlook, By Patient Care Management (2020-2028) ($MN)
- Table 13 Global Cancer Registry Software Market Outlook, By Deployment Model (2020-2028) ($MN)
- Table 14 Global Cancer Registry Software Market Outlook, By Cloud-based (2020-2028) ($MN)
- Table 15 Global Cancer Registry Software Market Outlook, By On-premise (2020-2028) ($MN)
- Table 16 Global Cancer Registry Software Market Outlook, By End User (2020-2028) ($MN)
- Table 17 Global Cancer Registry Software Market Outlook, By Research Centre (2020-2028) ($MN)
- Table 18 Global Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2020-2028) ($MN)
- Table 19 Global Cancer Registry Software Market Outlook, By Private Payers (2020-2028) ($MN)
- Table 20 Global Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2020-2028) ($MN)
- Table 21 Global Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2020-2028) ($MN)
- Table 22 North America Cancer Registry Software Market Outlook, By Country (2020-2028) ($MN)
- Table 23 North America Cancer Registry Software Market Outlook, By Type (2020-2028) ($MN)
- Table 24 North America Cancer Registry Software Market Outlook, By Standalone Software (2020-2028) ($MN)
- Table 25 North America Cancer Registry Software Market Outlook, By Integrated Software (2020-2028) ($MN)
- Table 26 North America Cancer Registry Software Market Outlook, By Database Type (2020-2028) ($MN)
- Table 27 North America Cancer Registry Software Market Outlook, By Public Database (2020-2028) ($MN)
- Table 28 North America Cancer Registry Software Market Outlook, By Commercial Database (2020-2028) ($MN)
- Table 29 North America Cancer Registry Software Market Outlook, By Functionality (2020-2028) ($MN)
- Table 30 North America Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2020-2028) ($MN)
- Table 31 North America Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2020-2028) ($MN)
- Table 32 North America Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2020-2028) ($MN)
- Table 33 North America Cancer Registry Software Market Outlook, By Patient Care Management (2020-2028) ($MN)
- Table 34 North America Cancer Registry Software Market Outlook, By Deployment Model (2020-2028) ($MN)
- Table 35 North America Cancer Registry Software Market Outlook, By Cloud-based (2020-2028) ($MN)
- Table 36 North America Cancer Registry Software Market Outlook, By On-premise (2020-2028) ($MN)
- Table 37 North America Cancer Registry Software Market Outlook, By End User (2020-2028) ($MN)
- Table 38 North America Cancer Registry Software Market Outlook, By Research Centre (2020-2028) ($MN)
- Table 39 North America Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2020-2028) ($MN)
- Table 40 North America Cancer Registry Software Market Outlook, By Private Payers (2020-2028) ($MN)
- Table 41 North America Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2020-2028) ($MN)
- Table 42 North America Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2020-2028) ($MN)
- Table 43 Europe Cancer Registry Software Market Outlook, By Country (2020-2028) ($MN)
- Table 44 Europe Cancer Registry Software Market Outlook, By Type (2020-2028) ($MN)
- Table 45 Europe Cancer Registry Software Market Outlook, By Standalone Software (2020-2028) ($MN)
- Table 46 Europe Cancer Registry Software Market Outlook, By Integrated Software (2020-2028) ($MN)
- Table 47 Europe Cancer Registry Software Market Outlook, By Database Type (2020-2028) ($MN)
- Table 48 Europe Cancer Registry Software Market Outlook, By Public Database (2020-2028) ($MN)
- Table 49 Europe Cancer Registry Software Market Outlook, By Commercial Database (2020-2028) ($MN)
- Table 50 Europe Cancer Registry Software Market Outlook, By Functionality (2020-2028) ($MN)
- Table 51 Europe Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2020-2028) ($MN)
- Table 52 Europe Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2020-2028) ($MN)
- Table 53 Europe Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2020-2028) ($MN)
- Table 54 Europe Cancer Registry Software Market Outlook, By Patient Care Management (2020-2028) ($MN)
- Table 55 Europe Cancer Registry Software Market Outlook, By Deployment Model (2020-2028) ($MN)
- Table 56 Europe Cancer Registry Software Market Outlook, By Cloud-based (2020-2028) ($MN)
- Table 57 Europe Cancer Registry Software Market Outlook, By On-premise (2020-2028) ($MN)
- Table 58 Europe Cancer Registry Software Market Outlook, By End User (2020-2028) ($MN)
- Table 59 Europe Cancer Registry Software Market Outlook, By Research Centre (2020-2028) ($MN)
- Table 60 Europe Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2020-2028) ($MN)
- Table 61 Europe Cancer Registry Software Market Outlook, By Private Payers (2020-2028) ($MN)
- Table 62 Europe Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2020-2028) ($MN)
- Table 63 Europe Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2020-2028) ($MN)
- Table 64 Asia Pacific Cancer Registry Software Market Outlook, By Country (2020-2028) ($MN)
- Table 65 Asia Pacific Cancer Registry Software Market Outlook, By Type (2020-2028) ($MN)
- Table 66 Asia Pacific Cancer Registry Software Market Outlook, By Standalone Software (2020-2028) ($MN)
- Table 67 Asia Pacific Cancer Registry Software Market Outlook, By Integrated Software (2020-2028) ($MN)
- Table 68 Asia Pacific Cancer Registry Software Market Outlook, By Database Type (2020-2028) ($MN)
- Table 69 Asia Pacific Cancer Registry Software Market Outlook, By Public Database (2020-2028) ($MN)
- Table 70 Asia Pacific Cancer Registry Software Market Outlook, By Commercial Database (2020-2028) ($MN)
- Table 71 Asia Pacific Cancer Registry Software Market Outlook, By Functionality (2020-2028) ($MN)
- Table 72 Asia Pacific Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2020-2028) ($MN)
- Table 73 Asia Pacific Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2020-2028) ($MN)
- Table 74 Asia Pacific Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2020-2028) ($MN)
- Table 75 Asia Pacific Cancer Registry Software Market Outlook, By Patient Care Management (2020-2028) ($MN)
- Table 76 Asia Pacific Cancer Registry Software Market Outlook, By Deployment Model (2020-2028) ($MN)
- Table 77 Asia Pacific Cancer Registry Software Market Outlook, By Cloud-based (2020-2028) ($MN)
- Table 78 Asia Pacific Cancer Registry Software Market Outlook, By On-premise (2020-2028) ($MN)
- Table 79 Asia Pacific Cancer Registry Software Market Outlook, By End User (2020-2028) ($MN)
- Table 80 Asia Pacific Cancer Registry Software Market Outlook, By Research Centre (2020-2028) ($MN)
- Table 81 Asia Pacific Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2020-2028) ($MN)
- Table 82 Asia Pacific Cancer Registry Software Market Outlook, By Private Payers (2020-2028) ($MN)
- Table 83 Asia Pacific Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2020-2028) ($MN)
- Table 84 Asia Pacific Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2020-2028) ($MN)
- Table 85 South America Cancer Registry Software Market Outlook, By Country (2020-2028) ($MN)
- Table 86 South America Cancer Registry Software Market Outlook, By Type (2020-2028) ($MN)
- Table 87 South America Cancer Registry Software Market Outlook, By Standalone Software (2020-2028) ($MN)
- Table 88 South America Cancer Registry Software Market Outlook, By Integrated Software (2020-2028) ($MN)
- Table 89 South America Cancer Registry Software Market Outlook, By Database Type (2020-2028) ($MN)
- Table 90 South America Cancer Registry Software Market Outlook, By Public Database (2020-2028) ($MN)
- Table 91 South America Cancer Registry Software Market Outlook, By Commercial Database (2020-2028) ($MN)
- Table 92 South America Cancer Registry Software Market Outlook, By Functionality (2020-2028) ($MN)
- Table 93 South America Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2020-2028) ($MN)
- Table 94 South America Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2020-2028) ($MN)
- Table 95 South America Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2020-2028) ($MN)
- Table 96 South America Cancer Registry Software Market Outlook, By Patient Care Management (2020-2028) ($MN)
- Table 97 South America Cancer Registry Software Market Outlook, By Deployment Model (2020-2028) ($MN)
- Table 98 South America Cancer Registry Software Market Outlook, By Cloud-based (2020-2028) ($MN)
- Table 99 South America Cancer Registry Software Market Outlook, By On-premise (2020-2028) ($MN)
- Table 100 South America Cancer Registry Software Market Outlook, By End User (2020-2028) ($MN)
- Table 101 South America Cancer Registry Software Market Outlook, By Research Centre (2020-2028) ($MN)
- Table 102 South America Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2020-2028) ($MN)
- Table 103 South America Cancer Registry Software Market Outlook, By Private Payers (2020-2028) ($MN)
- Table 104 South America Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2020-2028) ($MN)
- Table 105 South America Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2020-2028) ($MN)
- Table 106 Middle East & Africa Cancer Registry Software Market Outlook, By Country (2020-2028) ($MN)
- Table 107 Middle East & Africa Cancer Registry Software Market Outlook, By Type (2020-2028) ($MN)
- Table 108 Middle East & Africa Cancer Registry Software Market Outlook, By Standalone Software (2020-2028) ($MN)
- Table 109 Middle East & Africa Cancer Registry Software Market Outlook, By Integrated Software (2020-2028) ($MN)
- Table 110 Middle East & Africa Cancer Registry Software Market Outlook, By Database Type (2020-2028) ($MN)
- Table 111 Middle East & Africa Cancer Registry Software Market Outlook, By Public Database (2020-2028) ($MN)
- Table 112 Middle East & Africa Cancer Registry Software Market Outlook, By Commercial Database (2020-2028) ($MN)
- Table 113 Middle East & Africa Cancer Registry Software Market Outlook, By Functionality (2020-2028) ($MN)
- Table 114 Middle East & Africa Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2020-2028) ($MN)
- Table 115 Middle East & Africa Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2020-2028) ($MN)
- Table 116 Middle East & Africa Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2020-2028) ($MN)
- Table 117 Middle East & Africa Cancer Registry Software Market Outlook, By Patient Care Management (2020-2028) ($MN)
- Table 118 Middle East & Africa Cancer Registry Software Market Outlook, By Deployment Model (2020-2028) ($MN)
- Table 119 Middle East & Africa Cancer Registry Software Market Outlook, By Cloud-based (2020-2028) ($MN)
- Table 120 Middle East & Africa Cancer Registry Software Market Outlook, By On-premise (2020-2028) ($MN)
- Table 121 Middle East & Africa Cancer Registry Software Market Outlook, By End User (2020-2028) ($MN)
- Table 122 Middle East & Africa Cancer Registry Software Market Outlook, By Research Centre (2020-2028) ($MN)
- Table 123 Middle East & Africa Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2020-2028) ($MN)
- Table 124 Middle East & Africa Cancer Registry Software Market Outlook, By Private Payers (2020-2028) ($MN)
- Table 125 Middle East & Africa Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2020-2028) ($MN)
- Table 126 Middle East & Africa Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2020-2028) ($MN)
